Furthermore, when compared to the DCM + AAV9-NC group, DCM + AAV9-NC + PPARα agonist group showed exacerbated cardiac function impairment (Fig. 6B; Table 1). The gene discussed is PPARA; the disease is familial dilated cardiomyopathy.